The invisible arm of immunity in common cancer chemoprevention agents.
The invisible arm of immunity in common cancer chemoprevention agents.
复制标题
DOI:
10.1158/1940-6207.capr-13-0036
复制
发表时间:
2013-08
期刊:
影响因子:
--
通讯作者:
Disis ML
中科院分区:
文献类型:
--
作者:
Marzbani E;Inatsuka C;Lu H;Disis ML
Immunoprevention refers to a strategy of preventing pathogen-associated and spontaneous cancers through the use of vaccines, antibodies, and immune modulators. Immune modulators function by enhancing the endogenous ability of the immune system to monitor for malignancy, so-called “immunosurveillance.” There is growing evidence that many of the most promising cancer chemoprevention agents including aspirin, COX-2 inhibitors, aromatase inhibitors, and bisphosphonates mediate their effects, in part, by enhancing immunosurveillance and reversing the immune evasive mechanisms that premalignant lesions employ. In the following review, we introduce critical components of the human immune surveillance system—dendritic cells, T cells, and immune suppressive cells—and discuss the emerging data suggesting that common chemoprevention agents may modulate the function of these immunologic cells.